96860-19-4Relevant articles and documents
Ratiometric fluorescence In3+ sensing via In3+-triggered tautomerization: Its applications to water samples, live cells and zebrafish
Chae, Ju Byeong,Do, Trinh N.,Kim, Cheal,Kim, Ki-Tae,Lim, Mi Hee,So, Haeri,Yi, Yelim,Yun, Dongju
, (2020)
A novel ratiometric fluorescence sensor NCS ((E)-N-(furan-2-ylmethyl)-2-(2-hydroxybenzylidene)hydrazine-1-carbothioamide) was synthesized by a combination of furfuryl isothiocyanate bearing hydrazine and salicylaldehyde. Sensor NCS exhibited a ratiometric fluorescent response toward In3+ via thioamide tautomerization with blue-shifted emission from 484 to 444 nm in a near-perfect aqueous solution. NCS displayed a linear ratiometric relationship to micromolar concentrations (0–60 μM) of In3+ and the detection limit was found to be 2.68 μM. Moreover, sensor NCS exhibited an excellent selectivity for sensing In3+ in real samples as well as live cell and zebrafish. The sensing mechanism was demonstrated through UV–visible, fluorescent and 1H NMR titrations, Job's plot, ESI-MS and theoretical calculations.
COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS
-
Page/Page column 177; 182; 183, (2022/03/22)
The present disclosure relates to copper complexes, pharmaceutical compositions comprising these complexes, chemical processes for preparing these complexes, and their use in the treatment of neurodegenerative disease, e.g., amyotrophic lateral sclerosis (ALS).
Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors
Jacobsen, E. Jon,Mitchell, Mark A.,Hendges, Susan K.,Belonga, Kenneth L.,Skaletzky, Louis L.,Stelzer, Lindsay S.,Lindberg, Thomas J.,Fritzen, Edward L.,Schostarez, Heinrich J.,O'Sullivan, Theresa J.,Maggiora, Linda L.,Stuchly, Christopher W.,Laborde, Alice L.,Kubicek, Marc F.,Poorman, Roger A.,Beck, Joan M.,Miller, Henry R.,Petzold, Gary L.,Scott, Pam S.,Truesdell, Scott E.,Wallace, Tanya L.,Wilks, John W.,Fisher, Christopher,Goodman, Linda V.,Kaytes, Paul S.,Ledbetter, Stephen R.,Powers, Elaine A.,Vogeli, Gabriel,Mott, John E.,Trepod, Catherine M.,Staples, Douglas J.,Baldwin, Eric T.,Finzel, Barry C.
, p. 1525 - 1536 (2007/10/03)
The synthesis and enzyme inhibition data for a series of thiadiazole urea matrix metalloproteinase (MMP) inhibitors are described. A broad screening effort was utilized to identify several thiadiazoles which were weak inhibitors of stromelysin. Optimization of the thiadiazole leads to include an α-amino acid side chain with variable terminal amide substituents provided a series of ureas which were moderately effective stromelysin inhibitors, with K(i)'s between 0.3 and 1.0 μM. The most effective analogues utilized an L-phenylalanine as the amino acid component. In particular, unsubstituted 46 had a K(i) of 710 nM, while the p-fluoro analogue 52 displayed increased potency (100 nM). Stromelysin inhibition was further improved using a pentafluorophenylalanine substituent which resulted in 70, a 14 nM inhibitor. While gelatinase inhibition was generally poor, the use of 1-(2-pyridyl)piperazine as the amide component usually provided for enhanced activity, with 71 inhibiting gelatinase with a K(i) of 770 nM. The combination of this heterocycle with a p-fluorophenylalanine substituent provided the only analogue, 69, with collagenase activity (13 μM). The SAR for analogues described within this series can be rationalized through consideration of the X-ray structure recently attained for 70 complexed to stromelysin. Uniquely, this structure showed the inhibitor to be completely orientated on the left side of the enzyme cleft. These results suggest that thiadiazole urea heterocycles which incorporate a substituted phenylalanine can provide selective inhibitors of stromelysin. Careful selection of the amide substituent can also provide for analogues with modest gelatinase inhibition.
